Upregulation of tumor suppressor gene ARID1A in CRC cell lines by HDACs pharmaceutical inhibitors seems to be a therapeutic approach for the treatment of ARID1A-deficient colorectal cancer. Here, ARID1A is linked to colorectal cancer.